CAFFEINE RENAL CLEARANCE AND URINE CAFFEINE CONCENTRATIONS DURING STEADY-STATE DOSING - IMPLICATIONS FOR MONITORING CAFFEINE INTAKE DURING SPORTS-EVENTS

被引:57
作者
BIRKETT, DJ [1 ]
MINERS, JO [1 ]
机构
[1] FLINDERS UNIV,BEDFORD PK,SA 5042,AUSTRALIA
关键词
CAFFEINE; PLASMA CONCENTRATION; URINE CONCENTRATION; SPORTS MONITORING;
D O I
10.1111/j.1365-2125.1991.tb05553.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Relationships between the plasma and urine concentrations and clearances of caffeine over successive dosage intervals at steady-state were investigated in six healthy volunteers administered caffeine, 150 mg 8 hourly for 6 days. 2 There was marked inter-individual variability in the urine (15.9-fold range) and steady-state plasma (8.1-fold range) concentrations of caffeine. 3 Urine caffeine concentrations were similar to those in plasma, with mean ratios (plasma:urine) ranging from 1.10 to 1.74. There was a good correlation (r = 0.93, P < 0.01) between caffeine urine and plasma concentrations. 4 There was a good correlation between caffeine renal clearance and urine flow rate (r = 0.89, P < 0.01). Caffeine renal clearance was not significantly different from the product of fu and urine flow rate, where fu is the fraction of caffeine unbound in plasma. Urine caffeine concentration and urine flow rate were not correlated (r = 0.14, P < 0.05). 5 The results indicate that caffeine is reabsorbed from the renal tubule to equilibrium with unbound caffeine in plasma. 6 A regulatory urine caffeine concentration limit of 12 mg l-1 may be exceeded by some individuals with coffee intake in the range 3 to 6 cups per day.
引用
收藏
页码:405 / 408
页数:4
相关论文
共 11 条
  • [1] CAFFEINE DISPOSITION AFTER ORAL DOSES
    BONATI, M
    LATINI, R
    GALLETTI, F
    YOUNG, JF
    TOGNONI, G
    GARATTINI, S
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (01) : 98 - 106
  • [2] BURG AW, 1975, TEA COFFEE TRADE J, V88, P40
  • [3] THE SIMULTANEOUS DETERMINATION OF THEOPHYLLINE, THEOBROMINE AND CAFFEINE IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    FOENANDER, T
    BIRKETT, DJ
    MINERS, JO
    WING, LMH
    [J]. CLINICAL BIOCHEMISTRY, 1980, 13 (03) : 132 - 134
  • [4] GILBERT RM, 1976, CAN MED ASSOC J, V114, P205
  • [5] ASSESSMENT OF CAFFEINE EXPOSURE - CAFFEINE CONTENT OF BEVERAGES , CAFFEINE INTAKE, AND PLASMA-CONCENTRATIONS OF METHYLXANTHINES
    LELO, A
    MINERS, JO
    ROBSON, R
    BIRKETT, DJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (01) : 54 - 59
  • [6] QUANTITATIVE ASSESSMENT OF CAFFEINE PARTIAL CLEARANCES IN MAN
    LELO, A
    MINERS, JO
    ROBSON, RA
    BIRKETT, DJ
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (02) : 183 - 186
  • [7] COMPARATIVE PHARMACOKINETICS OF CAFFEINE AND ITS PRIMARY DEMETHYLATED METABOLITES PARAXANTHINE, THEOBROMINE AND THEOPHYLLINE IN MAN
    LELO, A
    BIRKETT, DJ
    ROBSON, RA
    MINERS, JO
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (02) : 177 - 182
  • [8] EFFECTS OF CIMETIDINE ON CAFFEINE DISPOSITION IN SMOKERS AND NONSMOKERS
    MAY, DC
    JARBOE, CH
    VANBAKEL, AB
    WILLIAMS, WM
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (05) : 656 - 661
  • [9] PLASMA AND SALIVARY PHARMACOKINETICS OF CAFFEINE IN MAN
    NEWTON, R
    BROUGHTON, LJ
    LIND, MJ
    MORRISON, PJ
    ROGERS, HJ
    BRADBROOK, ID
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (01) : 45 - 52
  • [10] PARSONS WD, 1978, CLIN PHARMACOL THER, V24, P40